Clinical Trial Update: A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating infliximab (Remicade) for fistulizing Crohn's disease has completed. The update does not provide the trial results in the provided info…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED